Diagnostic News and Research

RSS

EULAR Patient Research Partners join in new research project to advance treatment of psoriatic arthritis

Eleven Patient Research Partners (PRPs) from three organizations (EULAR, GRAPPA-EU, and EUROPSO) participate in the new research project HIPPOCRATES, ensuring the patients' perspective is preserved and prioritized in all research activities to maximize the project's impact.

2 Jul 2021

UCLA professor honored for contributions to the field of hematology

Dr. Elizabeta Nemeth, professor of medicine and director of the Center for Iron Disorders at the David Geffen School of Medicine at UCLA, has been awarded the 2021 William Dameshek Prize by the American Society of Hematology (ASH) for her contributions to the field of hematology.

2 Jul 2021

Study demonstrates successful postinfection treatment for SARS-CoV-2

A recent study by Kansas State University virologists demonstrates successful postinfection treatment for SARS-CoV-2, the virus that causes COVID-19.

2 Jul 2021

Flinders University sleep experts test new mattress sensor

Flinders University sleep experts are becoming embedded in a new trial to help people with their individual sleep disorders - via tests on a new mattress sensor.

2 Jul 2021

Hospital prices must now be transparent. For many consumers, They’re still anyone’s guess.

A colonoscopy might cost you or your insurer a few hundred dollars — or several thousand, depending on which hospital or insurer you use.

2 Jul 2021

Clinic Mandates Surgical Simulation Training After Research Indicates Improved Performance

Independent surgical simulation training becomes the new normal for students at the Pan Am Clinic.

From VirtaMed 2 Jul 2021

Genetic variants in a neuro-associated gene cause neurodevelopmental disorder, finds study

Mayo Clinic researchers have discovered that genetic variants in a neuro-associated gene called SPTBN1 are responsible for causing a neurodevelopmental disorder. The study, published in Nature Genetics, is a first step in finding a potential therapeutic strategy for this disorder, and it increases the number of genes known to be associated with conditions that affect how the brain functions.

2 Jul 2021

Hi-tech lab taps advanced technology to boost Singapore's future pandemic response

Nanyang Technological University, Singapore (NTU Singapore) and Pathnova Laboratories, a medical diagnostic company backed by Temasek Life Sciences Accelerator and headquartered in Temasek Life Sciences Laboratory, is contributing to Singapore's COVID-19 diagnostic capability through its partnership in a new clinical diagnostic laboratory.

2 Jul 2021

FDA's new Cyclospora Prevention, Response and Research Action Plan released

As part of our ongoing efforts to combat foodborne illness and aligned with our New Era of Smarter Food Safety initiative, today, the U.S. Food and Drug Administration released the Cyclospora Prevention, Response and Research Action Plan.

1 Jul 2021

New mobile app could be useful in assessing symptom severity in chronic fatigue syndrome

Chronic fatigue syndrome / myalgic encephalomyelitis (CFS/ME) is a disabling disease, in which people have great difficulties in carrying out their daily activities.

1 Jul 2021

Study evaluates neutralizing antibody responses elicited by the Pfizer/BioNTech COVID-19 vaccine

A recent Diagnostics study discusses the specific antibody response that occurred in individuals after they had received the SARS-CoV-2 vaccine.

1 Jul 2021

ERS Genomics and Nippon Gene sign CRISPR/Cas9 license agreement

ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Nippon Gene Co., Ltd (Nippon Gene), a manufacturer of genetic engineering research reagents and diagnostic reagents for humans, animals, and plants, today announced a non-exclusive license agreement granting Nippon Gene access to ERS Genomics’ CRISPR/Cas9 patent portfolio.

1 Jul 2021

Frequent testing improves the detection of SARS-CoV-2

Detecting SARS-CoV-2, the virus that causes COVID-19, improves with regularity of testing, whether using rapid antigen tests or PCR molecular tests

1 Jul 2021

Frequent testing increases chance of detecting COVID-19 infections

The chance of detecting the virus that causes COVID-19 increases with more frequent testing, no matter the type of test, a new study found. Both polymerase chain reaction and antigen tests, paired with rapid results reporting, can achieve 98% sensitivity if deployed at least every three days.

30 Jun 2021

Researchers identify specific biomarkers for coronary microvascular disease

Although cardiovascular disease is the main cause of illness among women in the U.S., certain conditions such as coronary microvascular disease (CMD) cannot be easily diagnosed. In a new study, researchers at the University of Illinois Urbana-Champaign have identified specific biomarkers for CMD, which might reduce future hospitalizations.

30 Jun 2021

Many women perceive financial barriers to cervical cancer screening

Among low-income, uninsured, or publicly insured women ages 25-64 years who were not up to date on cervical cancer screening, 72% perceived financial barriers to screening.

29 Jun 2021

Non-invasive sensor technology to be tested in a world-first sleep disorder trial

A world-first sleep disorder diagnosis and monitoring trial will be conducted using invisible sensor technology developed at RMIT University.

29 Jun 2021

The technology behind face masks that can diagnose COVID-19

Researchers have recently incorporated technology into standard face masks to detect the presence of SARS-CoV-2.

29 Jun 2021

Nanotechnology and the fight against COVID-19

In a review paper published in the open-access MDPI journal Viruses, a team of researchers explored the potential of nanotechnology to alleviate the current and future coronavirus burden. The team focused on its potential role in the detection, diagnosis, protection, and treatment of SARS-CoV-2 infection.

29 Jun 2021

Rapid test kit for malaria delivers results in 30 minutes

A team of scientists from Nanyang Technological University, Singapore (NTU Singapore) has developed a test kit for malaria that delivers results in 30 minutes. The kit could facilitate the diagnosis of malaria in the field, as the equipment needed is anticipated to be lightweight, easy-to-use, and able to detect the disease in its early stages.

29 Jun 2021

Diagnostic News and Research

EULAR Patient Research Partners join in new research project to advance treatment of psoriatic arthritis

UCLA professor honored for contributions to the field of hematology

Study demonstrates successful postinfection treatment for SARS-CoV-2

Flinders University sleep experts test new mattress sensor

Hospital prices must now be transparent. For many consumers, They’re still anyone’s guess.

Clinic Mandates Surgical Simulation Training After Research Indicates Improved Performance

Genetic variants in a neuro-associated gene cause neurodevelopmental disorder, finds study

Hi-tech lab taps advanced technology to boost Singapore's future pandemic response

FDA's new Cyclospora Prevention, Response and Research Action Plan released

New mobile app could be useful in assessing symptom severity in chronic fatigue syndrome

Study evaluates neutralizing antibody responses elicited by the Pfizer/BioNTech COVID-19 vaccine

ERS Genomics and Nippon Gene sign CRISPR/Cas9 license agreement

Frequent testing improves the detection of SARS-CoV-2

Frequent testing increases chance of detecting COVID-19 infections

Researchers identify specific biomarkers for coronary microvascular disease

Many women perceive financial barriers to cervical cancer screening

Non-invasive sensor technology to be tested in a world-first sleep disorder trial

The technology behind face masks that can diagnose COVID-19

Nanotechnology and the fight against COVID-19

Rapid test kit for malaria delivers results in 30 minutes

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News